MyFinsight
Home
Blog
About
Regen BioPharma Inc (RGBP)
Regen BioPharma Inc (RGBP)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$32
Unit: Dollar
Positive Cash Flow Breakdown
Changes in derivative liability
Borrowings from notes payable to...
Common stock issued for expenses
Others
Negative Cash Flow Breakdown
Net income (loss)
Repayment of notes payable to re...
Increase ( decrease) in unearned...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income (loss)
-637,785
991,927
-967,853
-572,469
Changes in derivative liability
623,200
-1,181,680
380,826
299,216
Increase (decrease) in interest expense attributable to amortization of discount
8,754
8,656
8,850
34,234
Common stock issued for compensation
0
0
400,000
-
Common stock issued for expenses
47,897
20,500
-
24,386
(increase) decrease in accounts receivable
27,425
27,424
27,425
27,726
(increase) decrease in prepaid expenses
-
-
-
0
Increase (decrease) in accounts payable
468
9,126
9,310
13
Increase (decrease) in accrued expenses
-7,538
147,302
29,991
63,981
Increase (decrease) in penalties
-
-
-
50,000
Increase ( decrease) in unearned income
-31,640
-31,640
-31,640
-31,640
Net cash provided by (used in) operating activities
-24,069
-63,234
-197,941
-160,005
Increase (decrease)in convertible notes payable
-
0
0
194,599
Increase (decrease) other liabilities
-
-
-
50,000
Increase (decrease)in notes payable
-
58,836
-58,836
-
Repayment of notes payable to related parties
58,836
-
-
-
Common stock issued for cash
0
50,000
191,800
58,200
Borrowings from notes payable to related parties
82,873
-49,910
-
149,631
Net cash provided by (used in) financing activities
24,037
58,926
132,964
227,799
Net increase (decrease) in cash
-32
-4,308
-64,977
67,794
Cash at beginning of period
4,578
4,578
69,555
716
Cash at end of period
239
271
4,578
69,555
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Borrowings from notes
payable to related...
$82,873
(-63.11%↓ Y/Y)
Net cash provided by
(used in) financing...
$24,037
(-89.30%↓ Y/Y)
Canceled cashflow
$58,836
Net increase
(decrease) in cash
-$32
(-103.06%↓ Y/Y)
Canceled cashflow
$24,037
Changes in derivative
liability
$623,200
(65.61%↑ Y/Y)
Common stock issued for
expenses
$47,897
(-53.82%↓ Y/Y)
Increase (decrease) in
interest expense...
$8,754
(-51.13%↓ Y/Y)
Increase (decrease) in
accounts payable
$468
(-42.08%↓ Y/Y)
Repayment of notes payable
to related parties
$58,836
Net cash provided by
(used in) operating...
-$24,069
(89.24%↑ Y/Y)
Canceled cashflow
$680,319
Net income (loss)
-$637,785
(9.15%↑ Y/Y)
Increase ( decrease) in
unearned income
-$31,640
(66.67%↑ Y/Y)
(increase) decrease in
accounts receivable
$27,425
(-66.67%↓ Y/Y)
Increase (decrease) in
accrued expenses
-$7,538
(-106.89%↓ Y/Y)
Buy us a coffee